Demo Day 2013: ProTransit Nanotherapy
Channel: UNeMed Corporation
Date: 26/11/2013

ProTransit Nanotherapy, LLC, is a seed stage company focused on delivering medication with unique nanoparticles that are nontoxic and biodegradable. The nanoparticles stabilize the drug, have a slow-release profile and can penetrate cell membranes to deliver powerful medications where they can be most effective. The first of several applications of this technology will be delivering antioxidant enzymes in sunscreens and cosmetics to deep layers of skin where it can help prevent premature wrinkles, age spots and even cancer.

On Oct. 7, 2013, UNeMed Corporation hosted its inaugural UNMC Startup Company Demonstration Day, bringing in eight companies formed on the basis of technologies developed and invented at the University of Nebraska Medical Center.